US4880635B1
(en)
*
|
1984-08-08 |
1996-07-02 |
Liposome Company |
Dehydrated liposomes
|
GB8609537D0
(en)
*
|
1986-04-18 |
1986-05-21 |
Ici Plc |
Polyesters
|
DE3720806C2
(de)
*
|
1986-07-03 |
1997-08-21 |
Clariant Finance Bvi Ltd |
Verwendung eines Stabilisators in Peroxydbleichverfahren
|
US4758435A
(en)
*
|
1986-08-11 |
1988-07-19 |
American Cyanamid Company |
Estradiol implant composition and method for preparation
|
DE3641692A1
(de)
*
|
1986-12-06 |
1988-06-09 |
Boehringer Ingelheim Kg |
Katalysatorfreie resorbierbare homopolymere und copolymere
|
DE3710175A1
(de)
*
|
1987-02-12 |
1988-08-25 |
Hoechst Ag |
Mehrteilige implantierbare arzneizubereitung mit langzeitwirkung
|
US5180765A
(en)
*
|
1988-08-08 |
1993-01-19 |
Biopak Technology, Ltd. |
Biodegradable packaging thermoplastics from lactides
|
AU634723B2
(en)
*
|
1988-08-08 |
1993-03-04 |
Biopak Technology, Ltd. |
Degradable thermoplastic from lactides
|
KR900701934A
(ko)
*
|
1988-08-08 |
1990-12-05 |
원본미기재 |
락티드로부터 분해성 열가소성 수지
|
US5424346A
(en)
*
|
1988-08-08 |
1995-06-13 |
Ecopol, Llc |
Biodegradable replacement of crystal polystyrene
|
US6323307B1
(en)
|
1988-08-08 |
2001-11-27 |
Cargill Dow Polymers, Llc |
Degradation control of environmentally degradable disposable materials
|
US5250584A
(en)
*
|
1988-08-31 |
1993-10-05 |
G-C Dental Industrial Corp. |
Periodontium-regenerative materials
|
JP2714454B2
(ja)
*
|
1988-11-07 |
1998-02-16 |
三井東圧化学株式会社 |
生体吸収性ポリエステルの製造方法
|
US4990336A
(en)
*
|
1989-02-08 |
1991-02-05 |
Biosearch, Inc. |
Sustained release dosage form
|
FR2654337B1
(fr)
*
|
1989-11-15 |
1994-08-05 |
Roussel Uclaf |
Nouvelles microspheres injectables biodegradables procede de preparation et suspensions injectables les renfermant.
|
US5126147A
(en)
*
|
1990-02-08 |
1992-06-30 |
Biosearch, Inc. |
Sustained release dosage form
|
DE4005415C2
(de)
*
|
1990-02-21 |
1996-04-11 |
Boehringer Ingelheim Kg |
Verfahren zum Herstellen von Polyestern auf der Basis von Hydroxycarbonsäuren
|
US5733566A
(en)
*
|
1990-05-15 |
1998-03-31 |
Alkermes Controlled Therapeutics Inc. Ii |
Controlled release of antiparasitic agents in animals
|
US5288496A
(en)
*
|
1990-05-15 |
1994-02-22 |
Stolle Research & Development Corporation |
Growth promoters for animals
|
MY108621A
(en)
*
|
1990-08-01 |
1996-10-31 |
Novartis Ag |
Polylactide preparation and purification
|
US6353030B1
(en)
*
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
ZA918168B
(en)
*
|
1990-10-16 |
1993-04-14 |
Takeda Chemical Industries Ltd |
Prolonged release preparation and polymers thereof.
|
IT1249045B
(it)
*
|
1991-02-21 |
1995-02-11 |
Himont Inc |
Processo per la sintesi allo stato solido di polimeri dell'acido lattico e prodotti cosi ottenuti
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6005067A
(en)
*
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US5294469A
(en)
*
|
1992-06-17 |
1994-03-15 |
Mitsui Toatsu Chemicals, Incorporated |
Industrial woven fabric and composite sheet comprising same
|
US5758053A
(en)
*
|
1992-07-22 |
1998-05-26 |
Hitachi, Ltd. |
Fault handling and recovery for system having plural processors
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
WO1994008090A1
(fr)
*
|
1992-10-02 |
1994-04-14 |
Cargill, Incorporated |
Papier pourvu d'un couchage en polymere de lactide stable a la fusion et procede de fabrication
|
US6005068A
(en)
*
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
WO1994008078A1
(fr)
*
|
1992-10-02 |
1994-04-14 |
Cargill, Incorporated |
Tissus de lactide polymere stables en fusion et procede de fabrication
|
US5643595A
(en)
*
|
1992-11-24 |
1997-07-01 |
Alkermes Controlled Therapeutics Inc. Ii |
Growth promoters for animals
|
TW333456B
(en)
*
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6090925A
(en)
|
1993-03-09 |
2000-07-18 |
Epic Therapeutics, Inc. |
Macromolecular microparticles and methods of production and use
|
JP3645906B2
(ja)
*
|
1993-11-19 |
2005-05-11 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
マイクロカプセル封入された3−ピペリジニル−置換1,2−ベンズイソオキサゾール類及び1,2−ベンズイソチアゾール類
|
AU6710196A
(en)
*
|
1995-08-29 |
1997-03-19 |
Kyowa Hakko Kogyo Co. Ltd. |
Process for producing polyhydroxy carboxylic acid
|
SE505146C2
(sv)
*
|
1995-10-19 |
1997-06-30 |
Biogram Ab |
Partiklar för fördröjd frisättning
|
EP0823448A4
(fr)
*
|
1996-02-23 |
1998-08-12 |
Kyowa Hakko Kogyo Kk |
Procede d'elaboration d'acide polyhydroxycarboxylique
|
US20070185032A1
(en)
*
|
1996-12-11 |
2007-08-09 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US5968895A
(en)
|
1996-12-11 |
1999-10-19 |
Praecis Pharmaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
US6126919A
(en)
*
|
1997-02-07 |
2000-10-03 |
3M Innovative Properties Company |
Biocompatible compounds for pharmaceutical drug delivery systems
|
US6663899B2
(en)
|
1997-06-13 |
2003-12-16 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
US6113947A
(en)
*
|
1997-06-13 |
2000-09-05 |
Genentech, Inc. |
Controlled release microencapsulated NGF formulation
|
ES2359973T3
(es)
*
|
1998-03-19 |
2011-05-30 |
MERCK SHARP & DOHME CORP. |
Composiciones poliméricas líquidas para la liberación controlada de sustancias bioactivas.
|
US6217844B1
(en)
|
1998-04-27 |
2001-04-17 |
Praecis Pharmaceuticals, Inc. |
Methods for detecting lesions in dense breast tissue using LHRH antagonists
|
DE60019638T2
(de)
|
1999-12-10 |
2005-09-22 |
Equipolymers Gmbh |
Katalysatorsysteme für polykondensationsreaktionen
|
US6960626B2
(en)
*
|
2000-01-21 |
2005-11-01 |
Cyclics Corporation |
Intimate physical mixtures containing macrocyclic polyester oligomer and filler
|
JP5046447B2
(ja)
*
|
2000-08-07 |
2012-10-10 |
和光純薬工業株式会社 |
乳酸重合体及びその製造方法
|
US6362308B1
(en)
|
2000-08-10 |
2002-03-26 |
Alkermes Controlled Therapeutics Inc. Ii |
Acid end group poly(d,l-lactide-co-glycolide) copolymers high glycolide content
|
ATE407960T1
(de)
*
|
2000-08-16 |
2008-09-15 |
Tyco Healthcare |
Absorbierendes polymerharz mit hoher konsistenz
|
US7750109B2
(en)
|
2000-09-01 |
2010-07-06 |
Cyclics Corporation |
Use of a residual oligomer recyclate in the production of macrocyclic polyester oligomer
|
US7767781B2
(en)
|
2000-09-01 |
2010-08-03 |
Cyclics Corporation |
Preparation of low-acid polyalkylene terephthalate and preparation of macrocyclic polyester oligomer therefrom
|
CA2451187C
(fr)
*
|
2001-06-22 |
2012-08-14 |
Southern Biosystems, Inc. |
Implants coaxiaux a liberation prolongee d'ordre 0
|
WO2003002551A1
(fr)
|
2001-06-27 |
2003-01-09 |
Cyclics Corporation |
Isolation, formulation et mise en forme d'oligoesters macrocycliques
|
AR034641A1
(es)
|
2001-06-29 |
2004-03-03 |
Takeda Pharmaceutical |
Composicion de liberacion controlada y metodo para producirla
|
TWI225416B
(en)
|
2001-06-29 |
2004-12-21 |
Takeda Chemical Industries Ltd |
Sustained-release composition and process for producing the same
|
JP2003192773A
(ja)
*
|
2001-12-26 |
2003-07-09 |
Mitsui Chemicals Inc |
生体吸収性ポリヒドロキシカルボン酸及びその製造法
|
US6849600B2
(en)
*
|
2002-03-25 |
2005-02-01 |
The Regents Of The University Of California, Berkeley |
Corticotropin-releasing hormone analogs
|
WO2004029129A1
(fr)
*
|
2002-09-24 |
2004-04-08 |
Asahi Kasei Chemicals Corporation |
Copolymere d'acide glycolique et son procede de production
|
EP1440992A1
(fr)
*
|
2003-01-21 |
2004-07-28 |
Société de Conseils de Recherches et d'Applications Scientifiques ( S.C.R.A.S.) |
Système catalytique de (co)polymérisation du lactide et du glycolide
|
US20050112087A1
(en)
*
|
2003-04-29 |
2005-05-26 |
Musso Gary F. |
Pharmaceutical formulations for sustained drug delivery
|
US20060193825A1
(en)
*
|
2003-04-29 |
2006-08-31 |
Praecis Phamaceuticals, Inc. |
Pharmaceutical formulations for sustained drug delivery
|
JP2008518881A
(ja)
|
2003-07-18 |
2008-06-05 |
オークウッド ラボラトリーズ,エル.エル.シー. |
高分子組成物中の高分子の分子量低下、不純物形成およびゲル化の防止
|
US20050143303A1
(en)
*
|
2003-12-26 |
2005-06-30 |
Nastech Pharmaceutical Company Inc. |
Intranasal administration of glucose-regulating peptides
|
US20060074025A1
(en)
*
|
2003-12-26 |
2006-04-06 |
Nastech Pharmaceutical Company Inc. |
Therapeutic formulations for transmucosal administration that increase glucagon-like peptide-1 bioavailability
|
US20080318837A1
(en)
*
|
2003-12-26 |
2008-12-25 |
Nastech Pharmaceutical Company Inc. |
Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide
|
US20060210614A1
(en)
*
|
2003-12-26 |
2006-09-21 |
Nastech Pharmaceutical Company Inc. |
Method of treatment of a metabolic disease using intranasal administration of exendin peptide
|
DE112005000965T5
(de)
*
|
2004-04-28 |
2007-03-22 |
Keio University |
Depolymerisationsverfahren für Polymere mit Esterbindung in der Hauptkette und Verfahren zur Herstellung von Polymeren mit Esterbindung in der Hauptkette aus dem Depolymerisationsprodukt
|
ATE490736T1
(de)
*
|
2004-05-21 |
2010-12-15 |
Micro Therapeutics Inc |
Mit biologischen oder biologisch abbaubaren oder synthetischen polymeren oder fasern umschlungene metallspulen zur embolisierung einer körperhöhle
|
US20070254314A1
(en)
*
|
2004-09-16 |
2007-11-01 |
Geier Mark R |
Methods of treating autism and autism spectrum disorders
|
US8845676B2
(en)
*
|
2004-09-22 |
2014-09-30 |
Micro Therapeutics |
Micro-spiral implantation device
|
DE102005019782A1
(de)
*
|
2005-04-28 |
2006-11-09 |
Dendron Gmbh |
Vorrichtung zur Implantation von Okklusionswendeln mit innenliegendem Sicherungsmittel
|
EP1716847B1
(fr)
*
|
2005-04-28 |
2008-01-02 |
Nipro Corporation |
Composition pharmaceutique bioabsorbable contenant un copolymère de PLGA
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
US7942867B2
(en)
*
|
2005-11-09 |
2011-05-17 |
The Invention Science Fund I, Llc |
Remotely controlled substance delivery device
|
EP1959987A2
(fr)
*
|
2005-12-08 |
2008-08-27 |
Nastech Pharmaceutical Company Inc. |
Delivrance par voie muqueuse de formulations stabilisees d'exendine
|
ES2493166T3
(es)
|
2006-11-01 |
2014-09-11 |
Ventana Medical Systems, Inc. |
Haptenos, conjugados de haptenos, composiciones de los mismos y método para su preparación y uso
|
TWI481424B
(zh)
|
2006-12-18 |
2015-04-21 |
Takeda Pharmaceutical |
緩釋性組成物及其製法
|
JP5249249B2
(ja)
|
2007-03-13 |
2013-07-31 |
コヴィディエン リミテッド パートナーシップ |
コイルと耐伸張性部材とが含まれているインプラント
|
CN102143736A
(zh)
|
2008-07-17 |
2011-08-03 |
梅里亚有限公司 |
增强聚原酸酯和它们的制剂的稳定性的方法
|
WO2010047674A1
(fr)
|
2008-10-20 |
2010-04-29 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Agonistes de faible poids moléculaire du récepteur de l’hormone stimulatrice de la thyroïde (tshr)
|
CA2740970A1
(fr)
|
2008-10-21 |
2010-04-29 |
Oregon Health & Science University |
Naphthamides en tant qu'agents anti-cancereux
|
CN101445595B
(zh)
*
|
2008-12-26 |
2011-01-19 |
上海新上化高分子材料有限公司 |
聚乙丙交酯及其制备方法和应用
|
WO2011094426A1
(fr)
|
2010-01-29 |
2011-08-04 |
The United State Of America, As Represented By The Secretary, Department Of Health & Human Services |
Inhibiteurs de caspases
|
AU2011237421B2
(en)
|
2010-04-08 |
2016-10-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inverse agonists and neutral antagonists for the TSH receptor
|
WO2012125486A1
(fr)
|
2011-03-11 |
2012-09-20 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Polychimiothérapie pour le traitement du cancer
|
EP2685985B1
(fr)
|
2011-03-17 |
2016-08-31 |
The U.S.A. As Represented By The Secretary, Department Of Health And Human Services |
Méthodes de traitement de la leucémie et de troubles à médiation par les protéines cbf et runx1
|
CN102329269B
(zh)
*
|
2011-06-30 |
2013-07-17 |
南京大学 |
仿生氯化肌酐胍催化缩聚法合成高分子量聚乳酸
|
CN102295765B
(zh)
*
|
2011-06-30 |
2012-11-28 |
南京大学 |
生物质肌酐催化共缩聚法合成聚乳酸-乙醇酸
|
WO2013039792A1
(fr)
|
2011-09-12 |
2013-03-21 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Immunogènes à base d'un épitope vih-1 gp120 v1v2
|
US20140234360A1
(en)
|
2011-09-30 |
2014-08-21 |
The United States of America, as represented by the Secretary, Dept.of Health and Human Services |
Influenza vaccine
|
US9249103B2
(en)
|
2012-01-13 |
2016-02-02 |
Oregon Health & Science University |
Compounds, compositions and associated methods comprising 3-aryl quinolines
|
ES2734567T3
(es)
|
2012-06-08 |
2019-12-10 |
Univ Pittsburgh Commonwealth Sys Higher Education |
Inhibidores de FBXO3
|
CN104884057B
(zh)
|
2012-11-13 |
2019-08-20 |
美国政府(由卫生和人类服务部的部长所代表) |
大麻素受体介导的化合物
|
US9775895B2
(en)
|
2012-12-12 |
2017-10-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
HIV therapeutics and methods of making and using same
|
US9676771B2
(en)
|
2013-05-16 |
2017-06-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Compounds for inhibiting drug-resistant strains of HIV-1 integrase
|
CA2924527C
(fr)
|
2013-09-20 |
2022-07-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Composes destines au traitement du cancer de la prostate
|
WO2015106003A1
(fr)
|
2014-01-08 |
2015-07-16 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Voies de ras en tant que marqueurs de protection contre le vih et méthode d'amélioration d'efficacité de vaccin
|
JP6762930B2
(ja)
|
2014-05-09 |
2020-09-30 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
カンナビノイド受容体メディエータとしてのピラゾール誘導体およびそれらの使用
|
EP4070795A1
(fr)
|
2014-08-25 |
2022-10-12 |
Salk Institute for Biological Studies |
Nouveaux inhibiteurs ulk1 et procédés les utilisant
|
EP3189067B1
(fr)
|
2014-09-04 |
2021-05-19 |
The United States of America, as represented by The Secretary, Department of Health and Human Services |
Protéines de l'enveloppe du vih-1 et leur utilisation
|
WO2016064716A1
(fr)
|
2014-10-20 |
2016-04-28 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Polythérapie basée sur un antagoniste du tshr et un inhibiteur de l'igfr
|
WO2016103238A1
(fr)
|
2014-12-24 |
2016-06-30 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Protéines du métapneumovirus f recombinant et leur utilisation
|
US10196372B2
(en)
|
2015-01-05 |
2019-02-05 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
MYC G-quadruplex stabilizing small molecules and their use
|
PE20180021A1
(es)
|
2015-02-20 |
2018-01-09 |
Univ Oregon Health & Science |
Derivados de sobetiroma
|
WO2016196646A1
(fr)
|
2015-06-04 |
2016-12-08 |
The United States Of America, As Represented By The Secretary, Departmet Of Health & Human Services |
Composés de médiation des récepteurs cannabinoïdes
|
EP3347047A1
(fr)
|
2015-09-09 |
2018-07-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Système d'administration de vecteurs d'expression et utilisation de ce dernier pour induire une réponse immunitaire
|
CN108699043A
(zh)
|
2016-03-04 |
2018-10-23 |
美国政府(由卫生和人类服务部的部长所代表) |
大麻素受体介导化合物
|
CN109475121B
(zh)
|
2016-05-18 |
2021-06-25 |
俄勒冈健康科学大学 |
苏比替罗衍生物
|
US20190255079A1
(en)
|
2016-06-16 |
2019-08-22 |
Acies Bio D.O.O. |
Compositions and methods useful for treating diseases characterized by insufficient pantothenate kinase activity
|
CA3043790A1
(fr)
|
2016-12-16 |
2018-06-21 |
Institute For Research In Biomedicine |
Nouvelles proteines f du vrs de pre-fusion recombinant et leurs utilisations
|
CA3073842A1
(fr)
|
2017-08-31 |
2019-03-07 |
Evonik Corporation |
Procede de purification de polymere resorbable ameliore
|
JP2021502807A
(ja)
|
2017-11-01 |
2021-02-04 |
ザ スクリプス リサーチ インスティテュート |
新規足場hiv−1ワクチン免疫原
|
WO2019118803A1
(fr)
|
2017-12-14 |
2019-06-20 |
The United States Of America, As Represented By The Secretary,Department Of Health And Human Services |
Entités chimiques pour l'activation lytique de kshv et ciblage thérapeutique d'enzymes/protéines virales
|
US11427542B2
(en)
|
2018-03-29 |
2022-08-30 |
Elex Biotech, Inc. |
Compounds for treatment of cardiac arrhythmias and heart failure
|
JP7520822B2
(ja)
|
2018-09-25 |
2024-07-23 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
2’-ハロゲン化-4’-チオ-2’-デオキシ-5-アザシチジンアナログおよびその使用
|
JP2022513449A
(ja)
|
2018-12-12 |
2022-02-08 |
オートバーン セラピューティクス,インク. |
新規な甲状腺模倣物
|
EP3931180A1
(fr)
|
2019-03-01 |
2022-01-05 |
Autobahn Therapeutics, Inc. |
Nouveaux thyromimétiques
|
EP3937917B1
(fr)
|
2019-03-11 |
2023-11-15 |
Oregon State University |
Analogues et dérivés de céphalotaxine et procédés de fabrication et d'utilisation des composés
|
JP2024522183A
(ja)
|
2021-06-09 |
2024-06-11 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
非標準g四重鎖構造に結合する化合物ならびにそれを作製および使用する方法
|
WO2023059867A1
(fr)
|
2021-10-08 |
2023-04-13 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Composés pour le traitement ou la prévention de la maladie d'alzheimer
|
WO2023146771A1
(fr)
|
2022-01-25 |
2023-08-03 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Promédicaments à base de gingérénone a en tant que composés sénothérapeutiques et procédés d'utilisation
|
WO2023177568A1
(fr)
|
2022-03-14 |
2023-09-21 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Composés modulant le récepteur cannabinoïde
|
WO2024151855A1
(fr)
|
2023-01-13 |
2024-07-18 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Inhibiteurs de transfert de brins intégrase à base de carbamoyl pyridone bicyclique
|